Literature DB >> 7672355

Amylin regulation of carbohydrate metabolism.

A Young1, R Pittner, B Gedulin, W Vine, T Rink.   

Abstract

This review describes how amylin may work in the control of carbohydrate metabolism by actions on gastric emptying and on muscle glycogen metabolism. Amylin, which is co-secreted with insulin from pancreatic beta-cells in response to nutrient stimuli, affects both carbohydrate absorption and carbohydrate disposal. Amylin appears to regulate carbohydrate metabolism as a partner to insulin. Defending fuel stores tends to be hierarchical; plasma glucose is defended first, then muscle glycogen, then liver glycogen, then fat. Fuel stores are replenished by both incorporating ingested nutrient and by translocating nutrient stores among body sites. Lactate may better be regarded as a vector of fuel transfer rather than a 'dead end' in metabolism. Amylin can promote the translocation of lactate from muscle to liver. The amylin effect, illustrated by the simultaneous decrease in muscle glycogen and increase in liver glycogen [53, 56], is similar to the catecholamine effect observed by Cori et al. [57]. Amylin thus may be important in maintaining liver glycogen stores via the Cori cycle and the 'indirect' glycogen synthesis pathway [58,59]. Unlike catecholamines, amylin does not mobilize fat or impede insulin action in adipose tissue [30,35]. It can supply lactate to the liver, and because lactate is a preferred lipogenic substrate [60], may thereby favour fat storage. Amylin may also help to control carbohydrate absorption via an 'entero-insular loop' to ensure that absorption from the gut remains within the regulatory limits for carbohydrate disposal by peripheral tissues. This regulatory system is essential for normal control of plasma glucose and appears to be disrupted in type-1 diabetes, an amylin-deficient state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7672355     DOI: 10.1042/bst0230325

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  7 in total

1.  Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells.

Authors:  J Z Bai; E L Saafi; S Zhang; G J Cooper
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

2.  Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.

Authors:  R A Kenley; S Tracht; A Stepanenko; M Townsend; J L'Italien
Journal:  AAPS PharmSciTech       Date:  2000-03-18       Impact factor: 3.246

3.  Pramlintide injection drug product robustness studies.

Authors:  R A Kenley; F Bancroft; J L'Italien; A Stepanenko; M Townsend; T Dixit
Journal:  AAPS PharmSciTech       Date:  2000-03-18       Impact factor: 3.246

4.  Isolation and identification of peptide degradation products of heat stressed pramlintide injection drug product.

Authors:  C Hekman; W DeMond; T Dixit; S Mauch; M Nuechterlein; A Stepanenko; J D Williams; M Ye
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

Review 5.  A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence.

Authors:  Abhinav Nath; Elizabeth Rhoades
Journal:  FEBS Lett       Date:  2013-03-01       Impact factor: 4.124

6.  Orthogonal HPLC methods for quantitating related substances and degradation products of pramlintide.

Authors:  W Demond; R A Kenley; J L Italien; D Lokensgard; G Weilersbacher; K Herman
Journal:  AAPS PharmSciTech       Date:  2000-03-24       Impact factor: 3.246

Review 7.  Drug therapy of postprandial hyperglycaemia.

Authors:  A D Mooradian; J E Thurman
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.